Form D · Biotechnology
Cell Care Therapeutics, Inc.
Monrovia, CA · CIK 0001659658
Offering snapshot reported Feb 14, 2017 · SEC filing
- Reported sold
- $815K Offering amount: $1.5M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 1, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 14, 2017 | Initial | $815,000 | No comparison | 17 | SEC filing |
| Dec 1, 2015 | Initial | $1,025,740 | No comparison | 37 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-280630
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None |
Source: Form D, filed Feb 14, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Veronique Jotterand | Director, Executive |
| Nicolas Sohl | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
805 South Shamrock Avenue
Monrovia, CA, 91016-3651
Monrovia, CA, 91016-3651